Atlas Trials

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

Clinical trial NCT04668768 · SUSPENDED

Trial details

NCT number
NCT04668768
Sponsor
Fox Chase Cancer Center
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2021-04-16
Primary completion
2024-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.